Asthma: Clinical Trials

37 trials for Asthma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

37 terminated. 37 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 437Terminated 37

Follow Asthma: new trials by email Literature Review of Asthma trials Research Report on Asthma

Trials (filtered) newest first · largest first

All 37 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Step-up to Medium Strength Triple Therapy vs High Strength ICS/LABA in Adult Asthmatics Uncontrolled on Medium Strength ICS/LABA
Administration via pressurized metered dose inhaler (pMDI) - Asthma
Phase 4TerminatedChiesi Farmaceutici S.p.A.3202022-02-252024-11-15
The Effect of NAC on Lung Function and CT Mucus Score
n-acetylcystine + albuterol, 0.9% saline + albuterol - Asthma
Phase 4TerminatedUniversity of California, San Francisco42019-02-202026-06-11
Comparison of Dexamethasone Oral Preparations to Assess Taste and Acceptance in Children With Asthma and Croup
Dexamethasone IV for PO, Dexamethasone crushed tablets - Asthma, Croup
Phase 4TerminatedVanderbilt University Medical Center402018-10-232021-11-08
Reducing Exercise-induced Bronchoconstriction in Children With Asthma and Obesity
Albuterol Sulfate, Interval Warm-up exercise - Asthma in Children, Obesity, Childhood
Phase 4TerminatedUniversity of Nevada, Las Vegas342018-09-182021-07-22
Comparison of Albuterol for Status Asthmaticus
preservative free albuterol - Status Asthmaticus
Phase 4TerminatedNorton Healthcare82018-09-102021-05-20
Inpatient Clinical Trial of NAC
N-acetylcysteine - Asthma
Phase 4TerminatedUniversity of California, San Francisco12018-07-062021-10-26
Targeted AntiBiotics for Chronic Pulmonary Diseases
Piperacillin/tazobactam, Ciprofloxacin - COPD, Respiratory Tract Infections
Phase 4TerminatedChronic Obstructive Pulmonary Disease Trial Network, Denmark512018-01-102023-05-25
PRISTINE - Personalised Approach to Improve aSThma prescrIbing iN childrEn
Montelukast or Salmeterol or Theophylline or Steroid - Asthma
Phase 4TerminatedBrighton and Sussex University Hospitals NHS Trust22017-07-012019-12-18
An Imaging Study Using PET/CT to Characterize the Effect of Intravenous Reslizumab on Airway Inflammation
Reslizumab, Fludeoxyglucose F 18 (FDG), Placebo - Asthma
Phase 4TerminatedTeva Branded Pharmaceutical Products R&D, Inc.52017-05-082021-11-09
Steroids in Children Hospitalized With Asthma
Dexamethasone, Prednisone - Asthma, Status Asthmaticus
Phase 4TerminatedUniversity of Florida62017-03-202019-06-21
Effects of Intranasal Fluticasone Plus Azelastine on Airway Inflammation in Patients With Asthma & Allergic Rhinitis
Azelastine-Fluticasone Nasal, Placebos - Asthma, Allergic, Rhinitis,Allergic
Phase 4TerminatedUniversity of Dundee72017-01-202019-04-08
C1-inhibitor in Allergic ASThma Patients
C1-inhibitor, Saline, Antibiotics - Asthma
Phase 4TerminatedT. van der Poll372016-11-162020-06-24
Clinical Trial of NAC in Asthma
n-acetylcystine, 0.9% saline - Asthma
Phase 4TerminatedUniversity of California, San Francisco12016-03-012019-08-20
Sputum-derived Cellular Targets After Xolair (Omalizumab)
Omalizumab, Placebo - Asthma
Phase 4TerminatedNYU Langone Health32016-01-012019-09-30
Small Airway Function of Fluticasone/Formoterol (Flutiform®) and Fluticasone/Salmeterol
Fluticasone/Formoterol, Fluticasone/Salmeterol - Asthma
Phase 4TerminatedMundipharma Korea Ltd152015-08-312018-05-16
Effect of Vitamin D as add-on Therapy for Vitamin D Insufficient Patients With Severe Asthma
Vitamin D3, Placebo - Asthma
Phase 4TerminatedJohannes Gutenberg University Mainz542015-06-262017-05-01
Azithromycin for Children Hospitalized With Asthma
Azithromycin, Placebo - Asthma
Phase 4TerminatedMontefiore Medical Center1592013-10-012020-08-13
Comparison of Nebulizers in ED in Pediatric Asthma Patients
Hudson RCI® nebulizer, NebuTech® HDN® nebulizer, Albuterol - Asthma
Phase 4TerminatedSeton Healthcare Family402013-09-012021-04-08
Study of Safety of Foradil in Patients With Persistent Asthma
Formoterol 12 mcg, Fluticasone propionate 100 mcg, Fluticasone propionate 250 mcg - Persistent Asthma
Phase 4TerminatedNovartis Pharmaceuticals8272013-05-012017-03-21
Inhaled Fluticasone Effects on Upper Airway Patency in Obstructive Lung Disease
Inhaled Fluticasone Propionate - Asthma, Chronic Obstructive Pulmonary Disease
Phase 4TerminatedVA Office of Research and Development252013-03-122020-02-05

Showing 20 of 37. Sign in to see all of them.

Narrower conditions

Asthma, Exercise-Induced (2)  ·  Pulmonary Disease, Chronic Obstructive (2)  ·  Status Asthmaticus (2)  ·  Angioedemas, Hereditary (1)  ·  Bronchiectasis (1)  ·  Croup (1)  ·  Dermatitis (1)  ·  Dermatitis, Atopic (1)  ·  Dyspnea (1)  ·  Hypersensitivity (1)  ·  Inflammation (1)  ·  Lung Diseases (1)  ·  Pediatric Obesity (1)  ·  Pseudomonas Infections (1)

Broader conditions

Bronchial Diseases (37)  ·  Hypersensitivity, Immediate (37)  ·  Immune System Diseases (37)  ·  Respiratory Hypersensitivity (37)  ·  Hypersensitivity (36)  ·  Respiratory Tract Diseases (36)  ·  Lung Diseases, Obstructive (35)  ·  Lung Diseases (34)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Pathologic Processes (3)  ·  Signs and Symptoms (3)  ·  Chronic Disease (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Disease Attributes (2)

Interventions

Albuterol (4)  ·  Fluticasone (4)  ·  Fluticasone-Salmeterol Drug Combination (4)  ·  Acetylcysteine (3)  ·  Budesonide (3)  ·  Mometasone Furoate (3)  ·  Sodium Chloride (3)  ·  montelukast (3)  ·  Adrenal Cortex Hormones (2)  ·  Azithromycin (2)  ·  Calcium Dobesilate (2)  ·  Ciprofloxacin (2)  ·  Dexamethasone (2)  ·  N-monoacetylcystine (2)  ·  Saline Solution (2)

Sponsors

University of California, San Francisco (3)  ·  GlaxoSmithKline (2)  ·  Novartis Pharmaceuticals (2)  ·  Organon and Co (2)  ·  Teva Branded Pharmaceutical Products R&D, Inc. (2)  ·  University of Alberta (2)  ·  Apieron (1)  ·  Boehringer Ingelheim (1)  ·  Boston Children's Hospital (1)  ·  Brighton and Sussex University Hospitals NHS Trust (1)  ·  Chiesi Farmaceutici S.p.A. (1)  ·  Chronic Obstructive Pulmonary Disease Trial Network, Denmark (1)  ·  Critical Therapeutics (1)  ·  Duke University (1)  ·  Johannes Gutenberg University Mainz (1)

Countries

United States (23)  ·  Canada (3)  ·  United Kingdom (3)  ·  Denmark (1)  ·  Germany (1)  ·  Hungary (1)  ·  Netherlands (1)

Top investigators

Irvin Mayers, MD, FRCPC (2)  ·  John Fahy, M.D, M.Sc. (2)  ·  Alyssa H Silver, MD (1)  ·  Brian Lipworth, MD (1)  ·  Chrsitopher Compton (1)  ·  Cornelis Wortel, MD, PhD (1)  ·  Dharini M Bhammar, Ph.D. (1)  ·  Diana S. Lee, MD (1)  ·  Donald Arnold, MD, MPH (1)  ·  Eric C Kleerup, MD (1)  ·  Fernando D. Martinez, MD (1)  ·  Jeffrey C Winer, MD (1)  ·  Jens-Ulrik Jensen, MD, Consultant, Phd (1)  ·  Joan Reibman, MD (1)

Results publications

PMID 18951618, PMID 24267370, PMID 26598458, PMID 27560168, PMID 31238116, PMID 34303860, PMID 35124256, PMID 36596609, PMID 38844921

NIH funding

2014 (1), 2015 (1), P01HL128191 (1), U10HL064287 (1), U10HL064288 (1), U10HL064295 (1), U10HL064305 (1), U10HL064307 (1), U10HL064313 (1)